Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
March 13, 2024
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
March 6, 2024
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.
March 5, 2024
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
February 27, 2024
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
February 21, 2024
Across the United States, more babies born at 22 weeks’ gestation are admitted to neonatal intensive care units (NICUs) and surviving in increasing numbers, according to a new study led by UTHealth Houston.
February 7, 2024
A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston.
February 6, 2024
Using the Nutrition Facts labels to make food choices is significantly associated with healthy eating among eighth and 11th grade students in Texas, although the proportion of students using nutrition labels to make their food choices is low, according to research from UTHealth Houston.
February 6, 2024
Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according to new research from UTHealth Houston.
January 18, 2024
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.
January 17, 2024
After children experienced severe traumatic brain injury, the infusion of bone marrow mononuclear cells derived from the patient’s own bones led to less time spent in intensive care, less intense therapy, and, significantly, the structural preservation of white matter, which constitutes about half the total volume of the brain, according to new research from UTHealth Houston.
Use the form below to perform a new search.